Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-07-29FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for Versacloz, a brand of clozapine, submitted by TruPharma LLC.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Sulforaphane to Reduce Symptoms of Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating sulforaphane for reducing symptoms in schizophrenia and schizoaffective disorder has completed with result…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Improving Visual Attention in Schizophrenia [NA]
Completed clinical trial investigating improving visual attention in schizophrenia and schizoaffective disorder; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Remediation of Auditory Recognition in Schizophrenia With tDCS [NA]
Completed clinical trial investigating remediation of auditory recognition in schizophrenia using transcranial Direct Current Stimulation (t…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating weekly exenatide injections as an adjunctive treatment for schizophrenia and schizoaffective disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers [NA]
Completed clinical trial studying motivational negative symptoms in schizophrenia with biomarkers; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Lurasidone Effects on Tissue Glutamate in Schizophrenia [Phase 4]
Phase 4 trial updates on lurasidone effects on tissue glutamate in schizophrenia and schizoaffective disorder; results posted after completi…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients [Phase 3]
Phase 3 trial comparing ziprasidone to other atypical antipsychotics in schizophrenia and schizoaffective disorder completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial update on the efficacy and safety of ziprasidone for acute exacerbation of schizophrenia or schizoaffective disorder.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 trial of ziprasidone in acute exacerbation of schizophrenia or schizoaffective disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs [Phase 4]
Phase 4 clinical trial updating on the effects of ziprasidone for schizophrenia or schizoaffective disorder in patients switched from other …
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders [Phase 2]
Phase 2 trial update evaluating the safety and tolerability of oral ziprasidone in children and adolescents with psychotic disorders complet…
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Clozapine filed by Teva Pharmaceuticals USA, Inc. The approval indicates an update to the Cl…
-
FDA approval · 2021-02-18FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application from Aurobindo Pharma Limited for clozapine, allowing the generic product to be marketed.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: MEtformin and Lorcaserin for WeighT Loss in Schizophrenia [Phase 4]
Phase 4 trial evaluating metformin and lorcaserin for weight loss in schizophrenia; study terminated with results posted.
-
FDA approval · 2021-02-01FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' supplemental application to add a generic aripiprazole orally disintegrating tablet.
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia [Phase 4]
Phase 4 trial update evaluating galantamine for cognitive impairments in schizophrenia and schizoaffective disorder; results posted after co…
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness [NA]
Clinical trial update on a mobile texting intervention for people with serious mental illness has completed with posted results.
-
FDA approval · 2020-10-30FDA Approved: PALIPERIDONE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for paliperidone (generic) submitted by NorthStar RxLLC.
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Comparison of E-health vs. In-person Multi-Family Group (MFG) [NA]
Completed clinical trial comparing e-health versus in-person multi-family group for schizophrenia-related conditions; results posted in 2020…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Simvastatin Addition for Patients With Recent-onset Schizophrenia [Phase 3]
Phase 3 trial assessing the addition of simvastatin in patients with recent-onset schizophrenia; study completed.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia [Phase 3]
A Phase 3 double-blind, placebo-controlled trial evaluating ondansetron in schizophrenia and related disorders has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life [NA]
A completed clinical trial evaluating the impact of physical activity on health outcomes in schizophrenia-related conditions; results posted…
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Brain Stimulation and Cognitive Training [NA]
A completed clinical trial from University of Michigan evaluating brain stimulation and cognitive training for bipolar disorder and schizoaf…
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic Stimulation [NA]
Completed clinical trial evaluating transcranial magnetic stimulation to improve neurocognitive deficits and function in schizophrenia. Resu…